Ipsen to Buy Swiss Biotech Memo in Deal That Could Top $800 Million
Corroborated by 3 sources from 3 publishers
TL;DR
Reports differ across sources; according to finance.yahoo.com, ipsen agreed to acquire Swiss biotech Memo Therapeutics AG on Wednesday for an upfront payment of 200 million euros, with additional milestone-based payments that could bring the total above 700 million euros, or roughly $800 million.
Sources
1
Dow Jones U.S. Business
https://www.wsj.com/health/pharma/ipsen-to-buy-swiss-biotech-memo-in-deal-that-could-top-800-million-30979c46?mod=pls_whats_news_us_business_f
2
Investing.com News
https://www.investing.com/news/stock-market-news/ipsen-to-buy-memo-therapeutics-for-over-799-million-93CH-4769593
3
Yahoo Finance News
https://finance.yahoo.com/healthcare/articles/ipsen-acquires-memo-therapeutics-800-124857010.html